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Abstract  
Rationale Endocannabinoids have emerged as a modulatory brain system affecting different types of 
synapses, broadly distributed throughout the CNS, which explain the diverse psychophysical effects 
observed following activation of the endocannabinoid system.  
Objectives and methods The present study aimed to characterize the effect of CB1-mediated activity in 
the visual thalamus. In vivo single-unit extracellular recordings were performed in anaesthetized adult 
pigmented rats, measuring visual and spontaneous activity, combined with application of CB1 receptor 
agonists (anandamide, 2-AG, and O2545) and one antagonist, AM251.  
Results CB1 receptors activation revealed two cellular populations, with excitatory effects on ∼28% of 
cells and inhibitory in ∼72%, actions which were blocked by the antagonist AM251. The agonist action 
significantly altered both spontaneous and visual activity, shifting the signal-tonoise ratio (S/N), with 
accompanying changes in the variability within the visual response. Increased responses by agonist 
application were accompanied by a decrease in S/N and an increase in variability, while those cells 
inhibited by the agonist showed an increase in S/N and a decrease in variability. There was no obvious 
correlation between the two effects and any other response property suggesting a more general role in 
modulating all information passing from LGN to cortex.  
Conclusions Our data support a role for CB1 at the level of the thalamus acting as a dynamic modulator 
of visual information being sent to the cortex, apparently maintaining the salience of the signal within 
upper and lower boundaries. This may account for some of the behavioral effects of cannabis.  
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Introduction  
The endocannabinoid system utilizes two well-characterized endogenous agonists, arachidonyl 
ethanolamide (anandamide, AEA) and sn-2 arachidonyl glycerol (2-AG) (Devane et al. 1992; Mechoulam 
et al. 1995; Sugiura et al. 1995) operating on two G-protein-coupled receptors, CB1 and CB2 (Matsuda et 
al. 1990; Munro et al. 1993).  
AEA and 2-AG are arachidonic acid derivatives stored as fatty acid components of membrane 
phospholipids (Di Marzo et al. 1994; Stella et al. 1997). Both ligands are released “on demand” by 
phosphorylation, following a depolarization-mediated increase in intracellular calcium (Sugiura et al. 
1996; Stella et al. 1997). The main receptors involved in AEA and 2-AG depolarization-mediated 
synthesis and release are mAChRs and group I mGluRs (Kim et al. 2002; Maejima et al. 2001), two of the 
major neurotransmitters involved in thalamic visual processing.  
In the brain, AEA and 2-AG have been shown to have modulatory effects, acting presynaptically on 
CB1 receptors and, mainly, inhibiting neurotransmitter release (Freund et al. 2003). This effect is more 
prominent in GABAergic and glutamatergic transmission (Schlicker and Kathmann 2001; Piomelli 2003), 
and has been well described in the hippocampus and cerebellum, where endocannabinoids mediate 
depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of 
excitation (DSE) by inhibiting GABAergic and glutamatergic neurotransmission, respectively (Wilson 
and Nicoll 2001; Diana et al. 2002). CB1 activation can also increase release of glutamate (Ferraro et al. 
2001) or ACh (Acquas et al. 2000) in a dose-dependent manner in cerebral cortex and hippocampus.  
In the visual system, there are well-documented psychotropic effects of Δ9 -tetrahydrocannabinol 
(THC) which includes a reduction in Vernier and Snellen tests of acuity, and alterations of 
photosensitivity and color discrimination (Kiplinger et al. 1971; Dawson et al. 1977; Russo et al. 2004). 
To date, there have been no reported studies on the effects of endocannabinoids on visual processing at 
the level of the thalamus.  
The dorsal lateral geniculate nucleus (dLGN) of the rat, as in cat and primate, is a dynamic relay 
station for visual information traveling from retina to cortex (Reese 1988; Sherman and Guillery 2002). 
Surprisingly, the primary visual cortex is the major modulatory input to the dLGN in the form of 
glutamatergic feedback connections from layer VI of the cortex. The dLGN also receives modulatory 
cholinergic inputs from the parabrachial region of the midbrain and GABAergic modulation from local 
and thalamic reticular nucleus interneurons (Sherman and Guillery 2002). Thus, the main 
neurotransmitters implicated in visual processing in dLGN are glutamate, GABA, and ACh that act over 
metabotropic and/or ionotropic receptors, all of which have previously been associated with 
endocannabinoid activity in other brain regions (Kim et al. 2002; Maejima et al. 2001; Haller et al. 2007). 
In the present study, we have recorded the activity of dLGN neurons extracellularly during 
spontaneous and visually driven conditions, in conjunction with manipulation of CB1 receptors.  
Materials and methods  
Animals and preparation  
All experiments were carried out in Lister hooded adult rats of either sex weighing between 250 and 350 
g. All procedures complied with the ethical use of animals specified in the European Communities 
Council Directive of November 24, 1986 (86/609/EEC) and Animals (Scientific Procedures) Act 1986, 
UK Home Office.  
We adopted previously published methods (Grieve 2005), briefly outlined below, to perform the 
experiments. Animals were anaesthetized intraperitoneally with a mixture of ketamine+xylazine (50 mg 
kg−1 +10 mg kg−1 ) for induction and isoflurane in 50%O2:50%N2O for surgery and maintenance (1.0–
2.0% surgery, 0.25–1.0% maintenance). To avoid eye movements, animals were paralyzed with 
gallamine triethiodide (20 mg kg1 ) through the lateral tail vein and artificially respired. ECG, rectal 
temperature, and end-tidal CO2 were measured and maintained continuously within normal physiological 
limits to ensure an appropriate level of anesthesia. Lidocaine gel was applied to pressure points and zero 
power contact lenses were placed in the eyes to protect the corneas. After each experiment, animals were 
killed with an anesthetic overdose without recovery from anesthesia.  
Animals were placed in a customized stereotaxic apparatus such that the head was secured in a 
horizontal orientation and the entire right visual hemifield was unobstructed. To access the left dLGN, the 
skull was exposed, a craniotomy was drilled ∼4.5 mm posterior to bregma and 3.5 mm lateral to the 
midline (Paxinos and Watson 1997), and the dura mater was retracted with a curved needle.  
Visual stimulation and recording  
We used tungsten microelectrodes (FHC Inc.), multibarreled glass micropipettes [for iontophoresis; 
Harvard Apparatus, pulled on a Narishige PE-2electrode puller (Narishige, Japan), broken back under a 
light microscope to a tip diameter of 3–5 μm] or single-barreled glass micropipettes (for pressure ejection; 
tip diameter 10 μm) glued under a light microscope to a tungsten microelectrode with dental cement. To 
locate the dLGN, these were advanced into the brain using a hydraulic microdrive (Narishige) while 
stimulating the appropriate eye with hand-held stimuli. After reaching the dLGN, cells were first driven 
qualitatively to localize the receptive field position. Quantitative visual stimuli, consisted on flashing 
spots and sinusoidal moving gratings, were displayed monocularly and under computer control (Visage; 
CRS Ltd., UK) on a computer monitor centered in the receptive field and placed either 14 or 28 cm from 
the eye. Cell type (ON or OFF), receptive field size, and preferred spatial and temporal frequency were 
determined for each cell. It is important to note that each experimental protocol included both visually 
driven activity and equal periods of spontaneous activity, randomly interleaved.  
The extracellular neural signal was continuously monitored on a 310 Tektronix Oscilloscope 
(Tektronix Holland N.V., The Netherlands) and audio monitor (FHC Inc.), amplified with a high-input 
impedance amplifier (AM System), voltage window discriminated, and fed into a computer via a digitizer 
interface (CED 1401 interface and Spike2 software; Cambridge Electronic Design, UK). Online analysis 
was carried out using custom-written Spike2 routines, and off-line with Spike2, MS Excel, and SPSS 
(SPSS Inc., Chicago, IL, USA).  
Drugs  
Anandamide (AEA, N-(2-hydroxyethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide), 2-AG ((5Z,8Z,11Z,14Z)-
5,8,11,14- eicosatetraenoic acid, 2-hydroxy-1-(hydroxymethyl) ethyl ester), AM251 (N-(piperidin-1-yl)-
5-(4-iodophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide), and O2545 
hydrochloride ((6aR,10aR)-6a,7,10,10a-tetrahydro-3-[5-(1H-imidazol-1-yl)-1, 1-dimethylpentyl]-6,6,9-
trimethyl-6H-dibenzo[b,d]pyran-1-ol hydrochloride) were obtained from Tocris, UK.  
AEA, 2-AG, and AM251 were dissolved in 1:1:18 cremophor/ethanol/saline. AEA, 2-AG, and 
AM251 (each with 0.5 mg/kg) were applied intravenously (Laviolette and Grace 2006; Lin and Lee 
2002). AEA (and vehicle alone) was also applied by pressure (2.0 mg/ml, Picospritzer II, Science 
Products GmbH, 5–10 psi).  
O2545 hydrochloride was applied iontophoretically (25 mM, pH 3.0 using a Medical Systems 
Neurophore) using multi-barreled pipettes also filled with 3 M NaCl for recording. Drug application 
currents were selected on the basis of initial qualitative studies and were applied in a range which did not 
saturate responses. When not in use, drug barrels were subjected to a retention current of 20 nA of 
appropriate polarity.  
Statistics  
Endocannabinoid-induced changes were measured at the time of maximal change in the firing rate after 
drug administration and were normalized to the control baseline. Only effects that were statistically 
significant versus control were considered for the analysis (p<0.05 one-way ANOVA or Friedman’s tests 
followed by Dunnett’s t test or Wilcoxon’s signed rank test when appropriate). Control values were 
calculated as the mean firing rate of at least two consecutive assessments before drug administration. 
Population data were analyzed using one-way ANOVA, Friedman’s test, Student’s t test, Mann–
Whitney’s test, or Wilcoxon’s signed rank test when appropriate. When necessary, post hoc comparisons 
were made. 
 
Signal-to-noise ratio In physiology experiments, salience of the stimulus with respect to the background 
firing (noise) has been considered as a measurement of the signal-tonoise ratio, calculated by dividing the 
visually evoked response value by the mean spontaneous firing rate for an equivalent time period. 
 
Fano factor (FF) We measured trial-by-trial variability by the FF, which is defined as the variance of the 
spike count divided by the mean. For each cell, we first obtained the response to the different repeated 
cycles of a grating stimulus and the spike count was the number of spikes elicited by each stimulus cycle. 
We obtained a value for each cycle of the visual stimulus from which we calculated variance and mean. 
Samples included similar time Windows in control and drug conditions, in both cases including the whole 
visual stimulus duration. 
 
Fig. 1 PSTHs depicting the opposite 
effects of CB1 activation by IV 
administration on the visual 
responses of two different dLGN 
cells: a decrease induced by 2-AG 
and b increase induced by AEA (0.5 
mg/kg, p<0.05 vs. control, 
Wilcoxon’s signed rank test in each 
case). Visual stimulus was a full field 
drifting grating with optimal 
characteristics for each cell: a spatial 
frequency was 0.01 c/deg and 
temporal frequency 2 c/s, bin size 50 
ms and in b spatial 0.01 c/deg, 
temporal frequency 1 c/s, and bin size 
40 ms. Ten trials in each case. c 
Averaged effect for AEA and 2-AG 
on visual response 
Results 
We successfully recorded the activity of 66 cells in the dLGN of 27 rats while manipulating CB1 receptor 
activation. Seven cells had inconsistent properties and were considered too variable to include in this 
study. The remaining sample included 44/59 (75%) ON center cells and 15/59 (25%) OFF center. 
Moreover, 37/59 (63%) showed a transient response versus 22/59 (37%) of the cells with clear sustained 
responses. The visual responses of all 59 cells were significantly altered by compounds manipulating CB1 
receptors and no cells were unaffected. 
CB1 receptors modulate visual responses 
We applied the cannabinoid agonists AEA and 2-AG (n=19 and eight cells, respectively) by intravenous 
administration, resulting in either significant excitation or inhibition of the visual responses. To illustrate 
these actions, Fig. 1a shows the response of one dLGN cell to a drifting grating of optimal temporal and 
spatial frequencies in control (left), 0.5 min after 2-AG injection (center) and recovery (right) after 10 
min. During CB1 receptor activation, a significant reduction of 58% is clear (p<0.05 vs. control, 
Wilcoxon’s signed rank test). Illustrating the opposite effect, Fig. 1b shows a second dLGN cell following 
AEA injection. In this case, an increase in firing occurred following AEA administration (p<0.05 vs. 
control, Wilcoxon’s signed rank test). These examples typify the two responses. Figure 1c shows the 
average effects for AEA (left) and 2-AG (right). In both cases, the most common effect was a decrease in 
the firing rate; this was observed in 84% of the cells during AEA application (16/19 cells) and in 87% of 
the cells during 2-AG (7/8 cells). Effects were maximal at 1.2±0.52 min after the injection for AEA and 
0.9±0.80 min for 2-AG. Recovery time was on average 3.6±0.55 min for AEA and 5.5±1.64 min for 2-
AG. Vehicle alone was injected in four cases with no significant effects on neuronal responses (data not 
shown). 
 
Fig. 2 a Responses of an example 
dLGN neuron to a grating of spatial 
frequency 0.03 c/deg and temporal 1 
c/s in control conditions (left PSTH), 
during the administration of AEA 
(center) and during the 
coadministration of AEA and AM251 
(right, 0.5 mg/kg IV, respectively). 
Bin size 50 ms and ten trials. b 
Averaged effect of AM251 on AEA 
actions in cells whose responses were 
inhibited (n=7) and on cells with 
responses increased (n=3). c 
Reversion of 2AG by simultaneous 
application of AM251. d Effect of 
AM251 alone on the response of 12 
cells. Data expressed as mean±SEM. 
*p<0.05 vs. control. Friedman’s test 
followed by Wilcoxon’s signed rank 
test 
 
  
In order to test the selectivity of the observed effect, we injected AEA or 2-AG alone and 
simultaneously with the selective CB1 receptor antagonist AM251 (n=12 cells). Figure 2a shows the 
response of a dLGN cell to visual stimulation (left) and how the reduction normally evoked by AEA 
injection (center) is prevented by AM251 (right), confirming a CB1-mediated action. Summaries of the 
effect of AM251 on AEA and 2-AG actions are shown in Fig. 2b, c. Interestingly, the administration of 
the antagonist alone (Fig. 2d) did not significantly affect neuronal response in the cells tested (n=12). 
Local application of AEA was tested by pressure ejection to ten cells. This significantly reduced 
visual responses in 8/10 (80%) of cells and increased visual responses in 2/10 (20%). These shifts in 
response magnitude were qualitatively and quantitatively similar to those seen using IV administration. 
The vehicle used for AEA solution was applied alone and shown to be without effect (n=2). These effects 
are illustrated in Fig. 3. 
Fig. 3 PSTHs depicting the effects of 
CB1 activation by local pressure 
ejection of AEA on the visual 
responses of two different dLGN 
cells (a, b) and the lack of effect of 
pressure ejection of the vehicle (c). In 
(a), the visual stimulus was a full 
field drifting grating with optimal 
characteristics; spatial frequency was 
0.03 c/deg and temporal frequency 1 
c/s, with 70-ms bins. In (b), the visual 
stimulus was a flashed spot of light 
(0.3 s duration, switched on 0.2 s 
after the start of the PSTH), bin size 
10 ms. In (c), the visual stimulus was 
a full field drifting grating with 
optimal characteristics; spatial 
frequency was 0.03 c/deg and 
temporal frequency 3 c/s, with 20-ms 
bins. Ten trials in each case  
 
We iontophoretically applied the water-soluble synthetic high affinity cannabinoid agonist O2545-
hydrochloride to 22 cells. This resulted in either enhanced (11/22) or decreased (11/22) visual responses 
during application. Enhanced responses were on average 63% greater than predrug control levels (p<0.05, 
Wilcoxon signed rank test), and decreased responses were on average reduced by 33% compared to the 
controls (p<0.05, Wilcoxon signed rank test). Effects were demonstrable within 1.0±0.3 min of the start 
of application. This is illustrated in Fig. 4a, b which show the visual response of two dLGN cells to an 
optimal flashed spot in control conditions, during application of O2545 and recovery after drug 
application, the upper records showing a 81% increase and the lower a 56% decrease in visual response 
magnitude. 
 
Fig. 4 PSTHs showing the visual 
responses of two dLGN neurons (a, 
b) to an optimal flashing spot in 
control situation (left) during the 
iontophoretic application of O2545 
(center) and after a recovery period 
(right). The upper example shows a 
clear response increase and the 
lower a response decrease. In both 
cases, bin size was 30 ms and p 
<0.05, Wilcoxon’s signed rank test 
 
As the effects of the agonists were similar whether given locally or systemically, we have combined 
the data for an overall analysis. The bar histogram in Fig. 5a compares the average magnitudes of the 
increases or decreases during systemic and local application for the different groups.  
Fig. 5 a The histogram shows the 
percentage change of the effect with 
respect to the control values (100%) 
for IV or local administration of the 
CB1 agonists (AEA, 2-AG, and 
O2545, overall n=59). Data are 
expressed as mean±SEM. b The 
summary histogram shows the 
change in visual response resulting 
from activation of CB1 receptors, as 
a percentage of the control value, for 
the whole population of 59 cells. It is 
clear that there are two distinct 
populations of cells, separated around 
zero, i.e., the visual responses of all 
cells were significantly affected, but 
were either enhanced (17) or 
inhibited (42). Cluster analysis (see 
text) reinforces this conclusion, 
including all but the extreme right 
four cells (i.e., 93% of the 
population) into two clusters 
 
 
The distribution of the effects on visual responses during agonist application is shown for all cells 
tested in Fig. 5b. This figure most clearly illustrates the existence of two subpopulations with a null 
between inhibitory (n=42) and excitatory effects (n=17). This conclusion is further supported by cluster 
analysis which indicates that two main clusters contain 93.5% of the sample, the first (72%) centered at 
−41% and the second (21%) centered at +56%. Only the four most extreme positive values were not 
covered by these clusters. However, although we could clearly identify two populations based upon the 
polarity of the effect of the drug (increased vs. decreased visual responses), we could find no systematic 
relationship between this and cell type (on vs. off or sustained vs. transient, see “Discussion”). 
Relationship between CB1 activation and different visualresponses 
Given the very clear separation of two response classes shown above, we attempted to dissect out the 
contribution of CB1 activation to different elements of the visual response, transient vs. sustained; the 
results were not statistically significant (data not shown). Secondly, we compared responses to static vs. 
moving visual stimuli (flashed spots vs. drifting gratings). Figure 6 shows the responses of a single dLGN 
cell to a drifting grating (Fig. 6a) and to a flashing spot (Fig. 6b). In each case, the stimulus was selected 
(size, spatial frequency, etc.) to produce a maximal response. In this example, there is a clear reduction in 
the visual responses during CB1 activation for both stimuli (p<0.05 vs. control, Wilcoxon’s signed rank 
test). The reduction was 52% for the grating and 51% for the spot. For the population, on average (shown 
in Fig. 6c), the reduction was 40±3.8% for gratings and 38±3.9% for spots, and the increase was 
67±11.2% for gratings and 84±26.8% for spots. Again, these differences were not statistically significant 
(p>0.05, Student’s t test). 
Relationship between visual responses and spontaneousactivity 
Above we reported only significant effects seen on visually driven activity, when cells were activated by 
appropriate visual stimuli. However, in our overall cell population (n=59), the effects of manipulation of 
CB1 receptor-driven activity were qualitatively similar when measured on visually elicited or 
spontaneous activity. That is to say, if visual responses were significantly decreased, the spontaneous 
activity was also significantly decreased, and vice versa. However, the changes in spontaneous activity 
were significantly greater than effects seen on driven activity, as measured as a percentage of the control 
levels (Fig. 7a). Cluster analysis (Fig. 7b) revealed similar clustering (inhibited, 42 cells, 72% of the 
population, centered on −59% and excited, 17 cells centered on +109%) to that obtained using evoked 
responses (see Fig. 5). These differential effects on spontaneous and visual evoked responses produced a 
quantitative change in the ratio between signal amplitude and the level of background activity (“signal-to-
noise ratio”)—significantly decreased in the case of cells excited by CB1 activation (Fig. 8a, left) and  
 Fig. 6 a Response of a dLGN 
neuron (ON center) to a grating of 
optimal characteristics, spatial 
frequency 0.01 c/deg, temporal 
frequency 1 c/s in control situation 
(left), and during iontophoretic 
application of O2545 (right). b 
Response of the same neuron as in 
(a) to a 20° diameter spot, also in the 
control situation (left) and during 
iontophoretic application of O2545 
(right). p<0.05 vs. control, 
Wilcoxon’s signed rank test. c 
Effect of the CB1 agonists tested 
(AEA, 2-AG, and O2545) during the 
presentation of spots or gratings of 
optimal characteristics. Data 
expressed as mean±SEM 
 
increased in cells inhibited (Fig. 8b, left). Results of the Fano analysis (which measures “noise” within the 
visual response) are shown in the right sides of Fig. 8a, b and show significant increases in “within 
stimulus noise” for cells which showing decreased signal-to-noise during drug action, and the reverse on 
cells which showed signal-to-noise increases. However, we were most interested to find that spontaneous 
activity is correlated with the effect of CB1 activation such that the spontaneous activity of cells inhibited 
by CB1 activation was significantly higher (9±1.2 spikes/s, n=42) than cells excited by CB1 activation 
(4.27±1.07 spikes/s, n=17; p<0.05, Mann–Whitney test) (Fig. 8c). This finding “binds together” many of 
the observations reported above. 
Fig. 7 a Bar histogram showing the different 
effects of CB1 activation on the visual 
responses versus spontaneous activity. Data 
are expressed as the mean±SEM 
(significantly different, p<0.05, one-way 
ANOVA followed by Bonferroni’s test). b 
The summary histogram shows the change 
in spontaneous activity resulting from 
activation of CB1 receptors, as a percentage 
of the control value, for the whole 
population of 59 cells. Again, the presence 
of two populations is clear 
 
 
 
 
 
  
Discussion 
It is clear that cannabis use can be associated with some visual abnormalities (Kiplinger et al. 1971; 
Dawson et al. 1977; Russo et al. 2004). Less clear, however, is the mechanism by which the exogenous 
cannabinoids might affect visual function at a cellular level, specifically considering the early visual 
pathways. Our data clearly show that exogenous applications of drugs known to activate the 
endocannabinoid receptor CB1 have significant effects on the visual responsiveness of cells in the rodent 
dLGN. The data show a clear division in our population with a significant majority of cells showing 
decreased visual responses, increased signal-to-noise and decreased response variability, and the second 
lesser population showing the opposite. 
Our approach has been to use several different compounds, known to act as agonists at the CB1 
receptor, given by several different routes, which together show significant effects on all the dLGN cells 
tested and confirm that these effects are generated locally within the dLGN and, by the use of the 
antagonist, are specific to CB1. Although the dorsal thalamus, including the dLGN, shows a low density 
of CB1 receptors (Herkenham et al. 1991; Pettit et al. 1998; Moldrich and Wenger 2000), Felder et al. 
(1996) showed high levels of anandamide (AEA) in the thalamus. This result is supported by high levels 
of fatty acid amide hydrolase, the degradative enzyme for AEA, in the thalamus (Thomas et al. 1997; 
Egertová et al. 1998). Furthermore, it has been shown that the thalamus, despite the moderate expression 
of CB1 receptors, has a high receptor/G-protein amplification ratio (Breivogel et al. 1997). 
The actual effects we have shown are clearly divided into excitation and inhibition (17/59 and 42/59 
cells, respectively), with our sample showing significant changes in both spontaneous and visually 
elicited activity. In all cases, these changes were of the same polarity for both spontaneous and visually 
driven spiking. Such a clear division of effects begs the question of what other factor or factors might co-
vary with the CB1-mediated effects. For example, cells in the rat dLGN can be subdivided along several 
lines—physiologically, for example, into Y-like and W-like populations (Hale et al. 1979; Reese 1988), 
sustained and transient, or even anatomically/chemically into excitatory (relay) or inhibitory cell types. 
Inhibitory interneurons are local GABAergic cells and are ∼20% of dLGN cells (Gabbott et al. 1986) 
which can be further differentiated into at least two populations by co-localization of nitric oxide synthase 
(Gabbott and Bacon 1994). While it would be interesting if CB1-mediated effects were different on relay 
versus inhibitory cells, our data do not answer this question. We can say that the full range of visual 
response types was found in both groups. Further, we did not find any cells in which CB1 induced 
inhibition changed to excitation during our recording periods and also that both response types were seen 
in the same animals and within the same penetrations, thereby supporting the view that these are truly 
separate cell groups. 
We also attempted to engage different circuit elements within the visual pathway. Thus, we compared 
responses to two different visual stimulus paradigms while modulating CB1 activity. Flashing visual 
stimulation clearly activates retinal input to the thalamus—but while clearly also activating retinal input, 
drifting, oriented grating stimuli are considered to be more powerful activators of corticofugal input to the 
dLGN (Cudeiro and Sillito 2006). Thus, we attempted to activate selectively the sub-families of 
glutamate receptors associated with retinogeniculate and corticogeniculate afferents (Godwin et al 1996). 
However, as clearly illustrated in Fig. 6, we could find no significant differences between spot and grating 
responses both including excitation and inhibition, and being equally affected. 
However, our data do support some interesting positive results: our populations of cell excited and 
cells inhibited by CB1 activation are separable if we consider two related elements. At a very simple 
level, cells which were inhibited by CB1 activation had significantly higher spontaneous firing levels than 
cells excited. This immediately suggests some form of gain control, but is even more interesting when we 
compared the magnitude of the drug-induced changes in spontaneous activity with the magnitude of 
change in visual responses, on a cell-by-cell basis. A very clear shift in the signal-to-noise ratio shows 
that when CB1 activation decreased the spontaneous activity, the signal-to-noise ratio was significantly 
increased. That is to say, the visual message given from thalamus to cortex is “cleaned” or “boosted”. 
Furthermore, the decrease in the FF in these cells (a decrease in variability during the visual response) 
would support this idea. Our population of cells excited by CB1 activation showed opposite 
characteristics. However, we are at this point unable to say what, if any, other factor (s) might put our cell 
populations into the high versus low spontaneous firing categories. What is known is that spontaneous 
activity is directly related to the state of the animal, being significantly higher when the animal is awake 
(Castro-Alamancos 2004). A decrease in spontaneous activity within the thalamus may have a direct 
impact on cortical state, favoring cortical deactivation or synchrony (Hirata and Castro-Alamancos 2010). 
Moreover, change in spontaneous activity at the level of the thalamus is able to switch the cortical state 
(Hirata and Castro-Alamancos 2010). Thus, our data support a view that the CB1 receptors, rather than 
favoring a particular “state”, may serve to maintain “balance” in an almost homeostatic way, preventing 
overexcitation or suppression while maintaining information throughput at some defined, perhaps 
optimal, level. 
 
Fig. 8 a Decrease of the signal-to-
noise ratio (left) and increase of the 
Fano factor (right) were statistically 
significant for those neurons that 
experienced a CB1-mediated 
increase in their responses (*p<0.05 
vs. control, Friedman’s test followed 
byWilcoxon’s signed rank test). b 
On the other hand, those neurons 
which decreased their responses due 
to the activation of the CB1 receptor 
showed a statistically significant 
increase in their signal-to-noise ratio 
(left) and a decrease (right) in value 
of the Fano factor. c Average 
spontaneous activity for those cells 
that showed increased firing and 
those showing decreased in presence 
of CB (*p<0.05 vs. control, 
Friedman’s test followed by 
Wilcoxon’s signed rank test) 
 
With this in mind, we note that thalamic cells are involved in multiple neural systems. As noted 
above, they receive “driving” glutamatergic inputs from the retina, but also modulatory inputs from the 
visual cortex and, significantly, cholinergic, noradrenergic, and serotonergic inputs (among others) 
fromthe brain stem(Steriade et al. 1988, 1997). These rich modulatory inputs modify neuronal responses 
at different levels: brainstem inputs are considered to regulate thalamic output globally, changing from 
sleep to wake (Steriade et al. 1997) and inattentive to attentive (Sherman and Koch 1986), with the 
cortico-thalamic input appearing to exert a more subtle and specific modulation, for example increasing 
tight synchrony between cells (Sillito and Jones 2002; Andolina et al. 2007) or modifying the response to 
specific parts of the stimulus (Rivadulla et al. 2002; Sillito et al. 1993; Cudeiro and Sillito 1996; de Labra 
et al. 2007). In such a complex scenario, endocannabinoids have multiple routes to regulate neuronal 
function. For example, it is known that AEA and 2-AG can inhibit the release of glutamate or GABA 
(Schlicker and Kathmann 2001; Piomelli 2003; Wilson and Nicoll 2001; Diana et al. 2002), i.e., inducing 
inhibition or excitation, as we see in our data. However, another possibility is an action on cholinergic 
synapses. CB1 receptor activation can increase or decrease ACh release in the hippocampus (Acquas et 
al. 2000; Tzavara et al. 2003) with Tzavara et al. (2003) showing that the effect is dose dependent, higher 
doses having an inhibitory effect. Interestingly, application of the CB1 antagonist AM251 alone, in a dose 
sufficient to block exogenous agonist activity, did not affect neuronal responses, indicating that 
endogenous CB release may not be active in local neuronal responses in our anaesthetized preparation, 
although the CB system may well be an integral part of the “global” modulatory systems arising from the 
brainstem. In our experimental preparation, the activity of these systems is likely to be significantly 
depressed (Steriade et al. 1997), which would be compatible with a low level of CB1 receptor-mediated 
activity. 
On balance, we think that the most plausible explanation for our data may be that in normal 
physiological function, the endocannabinoid system (through CB1 receptor activation) acts to a greater or 
lesser degree simultaneously on all three synaptic types, perhaps with each of them having different 
effects on interneurons or relay cells, with the final result determined by which of the systems is the most 
relevant at a given time. This would serve to maintain thalamic activity in a middle, moderate range, 
boosting and clarifying low amplitude signals and avoiding saturation at higher levels. Exogenously 
applied cannabinoids, as in the “recreational” drug use of cannabis, could clearly disturb this role, giving 
rise to subtle shifts in thalamocortical inputs to the cortex, in turn affecting higher functions, manifesting 
in the visual behavioral responses reported in the literature (Kiplinger et al. 1971; Dawson et al. 1977; 
Russo et al. 2004). 
While more work is necessary to clarify the mechanisms, clearly CB1 receptors are involved in a 
complex modulation of synaptic communication within the thalamus, previously undescribed, with 
fundamental consequences for the transfer of sensory information to the cortex. 
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